Therapeutic effects of clozapine on tardive dyskinesia

Cognitive and Behavioral Practice

Volumn 5, Issue 1, 1998, Pages 123-131

  Nair, Chand J ^a   Abraham, George ^b   Stanilla, Joseph K ^b   Tracy, Joseph I ^b   De Leon, Jose ^b   Simpson, George M ^b   Josiassen, Richard C ^b  

^a Allegheny University   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; COMORBIDITY; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032406847     PISSN: 10777229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1077-7229(98)80024-2     Document Type: Article

References (27)

1. Bellack, A. S., Mueser, K. T., Gingerich, S., & Agresta, J. (1997). Social skills training for schizophrenia. A step-by-slep guide. New York: Guilford Press.
2. Buckley, P. F., & Meltzer, H. Y. (1995). Treatment of schizophrenia. In A. F. Schatzberg & C. B. Nemeroff (Eds.), The American Psychiatric Press textbook of psychopharmacology (pp. 615-639). Washington, DC: American Psychiatric Press.
3. Caine, E., Polinsky, R., Kartzinel, R., & Ebert, M. (1979). The trial use of clozapine for abnormal involuntary movement disorders. American Journal of Psychiatry, 136, 317-320.
4. Carroll, B. J., Curtis, G. C., & Kokmen, K. (1977). Paradoxical response to dopamine agonists in tardive dyskinesia. American Journal of Psychiatry, 134, 785-789.
5. Casey, D. E. (1989). Clozapine: Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology, 99, S47-S53.
6. Chakos, M. H., Alvir, J. M. J., Woerner, M. G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J. M., Borenstein, M., & Lieberman, J. A. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Archives of Central Psychiatry, 3, 313-319.
7. Cole, J. O., Gardos, G., & Tarsy, D. (1980). Drug trials in persistent dyskinesia. In W. E. Fann, R. C. Smith, J. M. Davis, & E. F. Domino (Eds.), Tardive dyskinesia: Research and treatment (pp. 419-427). New York: SP Medical and Scientific Books.
8. Gerbino, L., Shopsin, B., & Collora, M. (1980). Clozapine in the treatment of tardive dyskinesia: An interim report. In W. E. Fann, R. C. Smith, J. M. Davis, & E. F. Domino (Eds.), Tardive dyskinesia: Research and treatment (pp. 475-489). New York: SP Medical and Scientific Books.
9. Gerlach, J., Koppelhus, P., Helweg, E., & Monrad, A. (1974). Clozapine and haloperidol in a single-blind cross-over trial: Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatrica Scandinavica, 50, 410-424.
10. Gerlach, J., & Peacock, L. (1994). Motor and mental side effects of clozapine. Journal of Clinical Psychiatry, 55(9 Suppl. B), 107-109.
11. Gerlach, J., Thorsen, K., & Fog, R. (1975). Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia, 40, 341-350.
12. Jeste, D. V., & Wyatt, J. (1982). Therapeutic strategies against tardive dyskinesia. Archives of General Psychiatry, 39, 803-816.
13. Kane, J., Honigfeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic. Archives of General Psychiatry, 45, 789-796.
14. Lieberman, J., Johns, C., Cooper, T., Pollack, S., & Kane, J. (1989). Clozapine pharmacology and tardive dyskinesia. Psychopharmacology, 99, S54-S59.
15. Lieberman, J. A., Saltz, B. L., Johns, C. A., Pollack, S., Bornstein, M., & Kane, J. (1991). The effects of clozapine on tardive dyskinesia. British Journal of Psychiatry, 158, 503-510.
16. Meltzer, H. Y., & Luchins, D. J. (1984). Effect of clozapine in severe tardive dyskinesia: A case report. Journal of Clinical Psychopharmacobgy, 4(5), 286-287.
17. Ruther, E. (1974). Leponox-Rundtischgesprach: Psychiatrische Klinik der FU Berlin, 14:12.
18. Schooler, N. R., & Kane, J. M. (1982). Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486-487.
19. Shopsin, B., Klein, H., Aaronson, M., & Collora, M. (1979). Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients. Archives of General Psychiatry, 36, 657-664.
20. Simpson, G. M., Lee, J. H., & Shrivastava, R. K. (1978). Clozapine in tardive dyskinesia. Psychopharmacology, 56, 75-80.
21. Simpson, G. M., Lee, J. H., Zoubok, B., & Gardos, G. (1979). A rating scale for tardive dyskinesia. Psychopharmacology, 64, 171-179.
22. Simpson, G. M., & Varga, E. (1974). Clozapine: A new antipsychotic agent. Current Therapeutic Research, Clinical and Experimental, 16(7), 679-686.
23. Simpson, G. M., & Varga, E. (1975). Clozapine: A new and unusual antipsychotic agent. Psychopharmacology Bulletin, 11(1), 14-15.
24. Singer, J. M. (1983). Clozapine and tardive dyskinesia [Letter]. Archives of General Psychiatry, 40, 347.
25. Small, J. G., Milstein, V., Marhenke, J. D., Hall, D. D., & Kellams, J. J. (1987). Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. Journal of Clinical Psychiatry, 48, 263-267.
26. Stanilla, J. K., & Simpson, G. M. (1995). Drugs to treat extrapyramidal side effects. In A. F. Schatzberg & C. B. Nemeroff(Eds.), The American Psychiatric Press textbook of psychopharmacology (pp. 199-281). Washington, DC: American Psychiatric Press.
27. Tamminga, C. A., Thaker, G. K., Moran, M., Kakigi, T., & Gao, X-M. (1994). Clozapine in tardive dyskinesia: Observations from human and animal model studies. Journal of Clinical Psychiatry, 55(9, Suppl. B), 102-106.